← FDA DRUG APPROVALS

FDA ANDA · ANDA070275

BETAMETHASONE DIPROPIONATE

Sponsor: FOUGERA PHARMS INC

APPLICATION
ANDA070275
TYPE
ANDA
ORIGINAL APPROVAL
1985-08-12
LATEST ACTION
1995-08-17
ROUTE
TOPICAL
DOSAGE FORM
LOTION
MARKETING STATUS
Prescription

Products

BETAMETHASONE DIPROPIONATEPrescription
BETAMETHASONE DIPROPIONATE EQ 0.05% BASE · LOTION · TOPICAL

Approval history

1995-08-17Labeling · Supplement 10AP
1995-01-06Manufacturing (CMC) · Supplement 9AP
1988-11-03Manufacturing (CMC) · Supplement 7AP
1988-11-03Manufacturing (CMC) · Supplement 8AP
1988-11-03Manufacturing (CMC) · Supplement 6AP
1987-10-21Manufacturing (CMC) · Supplement 4AP
1987-05-29Manufacturing (CMC) · Supplement 5AP
1986-03-28Manufacturing (CMC) · Supplement 1AP
1986-03-28Manufacturing (CMC) · Supplement 2AP
1985-08-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →